Efficacy and Safety of Botulinum Toxin at Moderate to Severe Glabellar Lines
Clinical trial NCT04830345 · COMPLETED
Trial details
- NCT number
- NCT04830345
- Sponsor
- EuBiologics Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-29
- Primary completion
- 2021-09-01
- Enrollment
- 290
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.